Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FNMWR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,817
Award facts
- Contract value 100% obligated
- $32,816.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials with a ceiling value of $32,816.60. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, utilizes firm fixed-price pricing and represents a tactical procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. No set-aside designation was applied to this award, indicating open competition among qualified vendors.
This delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for oncology treatments and specialty medications supporting Department of Defense healthcare facilities. Keytruda, an immunotherapy treatment used in cancer care, reflects the company's portfolio of high-value pharmaceutical products distributed to military medical installations. Through the SPE2DB program, DMS Pharmaceutical Group maintains consistent access to deliver prescription medications, biologics, and medical consumables to support DoD healthcare requirements nationwide, leveraging its small business status and established vendor relationships with DLA.
Quick answers
Who was awarded contract SPE2DB25FNMWR?
SPE2DB25FNMWR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FNMWR worth?
The government has obligated $32,817 on SPE2DB25FNMWR.
Is contract SPE2DB25FNMWR an order under another contract?
Yes. SPE2DB25FNMWR is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMWR competed?
The extent of competition for SPE2DB25FNMWR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award